Udayavni Special

Russian firm looking for partnership with India to produce COVID-19 vaccine


PTI, Aug 21, 2020, 9:21 AM IST

New Delhi: Russia is looking for a partnership with India for producing COVID-19 vaccine Sputnik V, Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF), said on Thursday, August 20.

Russian President Vladimir Putin had announced that his country has developed the world’s first vaccine against COVID-19, which works “quite effectively” and forms a “stable immunity” against the disease.

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, along with the RDIF. The vaccine has not been tested in Phase 3 or larger clinical trials.

Addressing an online press briefing, Dmitriev said several nations are interested in the production of the vaccine from countries in Latin America, Asia, and the Middle East.

“The production of the vaccine is a very important issue. Currently, we are looking for a partnership with India. We believe that they are capable of producing the Gamaleya vaccine and it is very important to say that those partnerships to produce the vaccine will enable us to cover the demand that we have,” he said.

Dmitriev said that Russia is looking forward to international cooperation.

“We are going to do clinical trials not just in Russia but also in the UAE, Saudi Arabia, probably in Brazil and India. We are planning to produce the vaccine in more than five countries and there is a very high demand from Asia, Latin America, Italy, and other parts of the world regarding the delivery of the vaccine,” he said.

Alexander Gintsburg, the director of the Gamaleya Research Institute of Epidemiology and Microbiology and an academician at the Russian Academy of Sciences, said more than 20,000 people have taken part in the clinical trials of vaccines and drugs, based on human adenoviruses or human adenoviral vectors.

“Vaccines do not contain live human adenoviruses, but human adenovirus vectors, that is, human viruses that cannot multiply in the body and are completely safe,” he said.

The Sputnik V vaccine consists of two shots that use different versions of adenoviruses virus types, some of which cause the common cold that the manufacturers have engineered to carry the gene for the surface protein of SARS-CoV-2 that causes COVID-19.

“The approach of the Gamaleya Institute with the vaccine, using two human adenoviruses serotypes: number 5 (Ad5) and number 26 (Ad26), has a clear advantage over the one-vector approach used by other developers,” Gintsburg said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Key accused in Kerala gold smuggling case ready to turn approver

Hindu Munnani founder Ramagopalan no more

K’taka COVID-19 update: 8856 new cases, 8890 discharges, 87 deaths on Sep 29

Mathura court dismisses plea seeking removal of mosque

Govt issues new guidelines; permits more activities in October

From Oct 1 few modified rules will come into force across country

CBI to decide on challenging special court verdict after consulting legal department: Counsel




Related Articles More

K’taka COVID-19 update: 8856 new cases, 8890 discharges, 87 deaths on Sep 29

India’s COVID-19 caseload races past 62 lakh, recoveries close to 52 lakh

‘Strict action against COVID-19 negligence, regulations for public to be out soon’

K’taka COVID-19 update: 10453 new cases, 6628 discharges, 136 deaths on Sep 28

Single-day COVID-19 cases in India drop below 75,000, recovery rate rises to 83.01 pc

MUST WATCH

Vijayapura families running funfairs stuck in city since 6 months

Pejawara seer Vishwaprasanna teertha swamiji message for babari verdict

Mangaluru: Fire guts 5 bikes in apartment building parking lot

BS Yediyurappa reacted to babri final verdict

Mangalore: Street Art that speaks on a social issue

Latest Additions

Key accused in Kerala gold smuggling case ready to turn approver

Hindu Munnani founder Ramagopalan no more

K’taka COVID-19 update: 8856 new cases, 8890 discharges, 87 deaths on Sep 29

No understanding with JD(S) for Nov 3 bypolls: K’taka Congress

Mathura court dismisses plea seeking removal of mosque

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.